Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 22;12(2):8312.
doi: 10.4081/dr.2020.8312. eCollection 2020 Sep 23.

Quality of life in black African patients with keloid scars

Komenan Kassi  1 , Kanga Kouame  1 , Alexandre Kouassi  1 , Ange Allou  1 , Isidore Kouassi  1 , Sarah Kourouma  1 , Elidje Ecra  1 , Abdoulaye Sangare  1
Affiliations

Quality of life in black African patients with keloid scars

Komenan Kassi et al. Dermatol Reports. .

Abstract

A keloid scar is a benign skin tumor and we aimed to assess the Quality of Life (QoL) of black Africans with keloid scars based on the Dermatology Life Quality Index (DLQI). We conducted a cross-sectional descriptive study in the department of dermatology of the teaching hospital of Treichville in Ivory Coast. We recruited 132 patients with keloid and 3612 dermatoses without keloid: The prevalence was 3.50% (132/3753). We included 120 patients aged from 16 to 63 years old, the sex ratio was 0.46 (38/82) and the mean age was 34.20 years. Keloid scars were mostly secondary to skin trauma in 30.00 % and infection in 21.67%. The commonest site was the ear in 29.17 %. We reported Keloid with pain in 53.33% and pruritus in 95.00%. We observed psychological impact in 65.83%. The DLQI scores were moderate and high in 61.66 %. QoL was impacted significantly when keloid was associated with pain (p=0.046), pruritus (p=0.81) and functional disorders (p=0.29). The DLQI score could be a valuable tool to assess QoL in black African patients with keloid, for better treatment option.

Keywords: Black African; DLQI; Keloid; QoL.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: the authors declare no potential conflict of interests.

References

    1. Hunasgi S, Koneru A, Vinishra M, et al. Keloid: a case report and review of pathophysiology and differences between keloid and hypertrophic scars. J Oral Maxillofac Pathol 2013;17:116-20. - PMC - PubMed
    1. Kelly P. Update on the management of keloids. Semin Cutan Med Surg 2009; 28:72-8. - PubMed
    1. Robles DT, Berg D. Abnormal wound healing: keloids: Clin Dermatol 2007;25:26-32. - PubMed
    1. Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011;17:113-25. - PMC - PubMed
    1. Bijlard E, Konwenberg C, Timman R, et al. Burden of keloid disease: a crosssectional health-related quality of life assessment. Acta Derma Venerol 2017;97:225-9. - PubMed